{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:05:37Z","timestamp":1785855937139,"version":"3.56.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1245\/s10434-020-09548-6","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T21:03:20Z","timestamp":1615842200000},"page":"5098-5109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Impact of Ipsilateral Supraclavicular Lymph Node Dissection (ISLND) for Breast Cancer Patients and a Nomogram for Predicting Ipsilateral Supraclavicular Pathological Complete Response (ispCR)"],"prefix":"10.1245","volume":"28","author":[{"given":"Minhao","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youzhao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuchun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"issue":"2","key":"9548_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.21037\/gs.2020.03.09","volume":"9","author":"X Ai","year":"2020","unstructured":"Ai X, Wang M, Li J, et al. Supraclavicular lymph node dissection with radiotherapy versus radiotherapy alone for operable breast cancer with synchronous ipsilateral supraclavicular lymph node metastases: a real-world cohort study. Gland Surg. 2020;9(2):329\u201341.","journal-title":"Gland Surg"},{"key":"9548_CR2","unstructured":"Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al., editors. American Joint Committee on Cancer. Manual for staging of cancer. 5th edition. Philadelphia: JB Lippincott; 1997."},{"key":"9548_CR3","doi-asserted-by":"crossref","unstructured":"Brito RA, Valero V, Buzdar AU, et al. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol. 2001;19(3):628\u201333.","DOI":"10.1200\/JCO.2001.19.3.628"},{"key":"9548_CR4","volume-title":"AJCC cancer staging manual","year":"2002","unstructured":"Greene FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging manual. 6th ed. New York: Springer; 2002.","edition":"6"},{"issue":"17","key":"9548_CR5","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1200\/JCO.2002.02.026","volume":"20","author":"SE Singletary","year":"2002","unstructured":"Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002;20(17):3628\u201336.","journal-title":"J Clin Oncol."},{"issue":"7","key":"9548_CR6","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","volume":"15","author":"B Fisher","year":"1997","unstructured":"Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 1997;15(7):2483\u201393.","journal-title":"J Clin Oncol"},{"issue":"16","key":"9548_CR7","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1200\/JCO.2005.07.032","volume":"23","author":"AU Buzdar","year":"2005","unstructured":"Buzdar AU, Ibrahim NK, Francis D, et al. Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol. 2005;23(16):3676\u201385.","journal-title":"J Clin Oncol"},{"issue":"36","key":"9548_CR8","doi-asserted-by":"publisher","first-page":"9304","DOI":"10.1200\/JCO.2005.02.5023","volume":"23","author":"BT Hennessy","year":"2005","unstructured":"Hennessy BT, Hortobagyi GN, Rouzier R, et al. Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol. 2005;23(36):9304\u201311.","journal-title":"J Clin Oncol"},{"issue":"12","key":"9548_CR9","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1002\/cncr.25152","volume":"116","author":"LS Dominici","year":"2010","unstructured":"Dominici LS, Negron Gonzalez VM, Buzdar AU, et al. Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer. Cancer 2010;116(12):2884\u20139.","journal-title":"Cancer"},{"key":"9548_CR10","doi-asserted-by":"publisher","first-page":"32585","DOI":"10.1038\/srep32585","volume":"6","author":"X Jin","year":"2016","unstructured":"Jin X, Jiang YZ, Chen S, Shao ZM, Di GH. A nomogram for predicting the pathological response of axillary lymph node metastasis in breast cancer patients. Sci Rep. 2016;6:32585.","journal-title":"Sci Rep"},{"issue":"4","key":"9548_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4174\/astr.2019.96.4.169","volume":"96","author":"HJ Choi","year":"2019","unstructured":"Choi HJ, Ryu JM, Kim I, et al. Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer. Ann Surg Treat Res. 2019;96(4):169\u201376.","journal-title":"Ann Surg Treat Res"},{"issue":"11","key":"9548_CR12","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1245\/s10434-016-5277-1","volume":"23","author":"J Vila","year":"2016","unstructured":"Vila J, Mittendorf EA, Farante G, et al. Nomograms for predicting axillary response to neoadjuvant chemotherapy in clinically node-positive patients with breast cancer. Ann Surg Oncol. 2016;23(11):3501\u20139.","journal-title":"Ann Surg Oncol"},{"key":"9548_CR13","doi-asserted-by":"crossref","unstructured":"Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 2002;41(3A):154\u201361.","DOI":"10.1046\/j.1365-2559.2002.14691.x"},{"issue":"2","key":"9548_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"9548_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1308\/003588412X13171221591736","volume":"94","author":"B Bisase","year":"2012","unstructured":"Bisase B, Kerawala C. Survey of UK practice for management of breast cancer metastases to the neck. Ann R Coll Surg Engl. 2012;94(7):484\u20139.","journal-title":"Ann R Coll Surg Engl"},{"issue":"2","key":"9548_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4048\/jbc.2015.18.2.167","volume":"18","author":"J Jung","year":"2015","unstructured":"Jung J, Kim SS, Ahn SD, et al. Treatment outcome of breast cancer with pathologically proven synchronous ipsilateral supraclavicular lymph node metastases. J Breast Cancer. 2015;18(2):167\u201372.","journal-title":"J Breast Cancer"},{"issue":"5","key":"9548_CR17","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1200\/JCO.2003.11.105","volume":"21","author":"IA Olivotto","year":"2003","unstructured":"Olivotto IA, Chua B, Allan SJ, Speers CH, Chia S, Ragaz J. Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer. J Clin Oncol. 2003;21(5):851\u20134.","journal-title":"J Clin Oncol"},{"issue":"2","key":"9548_CR18","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.ijrobp.2006.08.040","volume":"67","author":"EH Huang","year":"2007","unstructured":"Huang EH, Strom EA, Valero V, et al. Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis. Int J Radiat Oncol Biol Phys. 2007;67(2):490\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9548_CR19","unstructured":"National Bureau of Statistics of the People\u2019s Republic of China. China Statistical Yearbook. Beijing: China Statistics Press; 2020."},{"issue":"4","key":"9548_CR20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0039-6109(16)46077-9","volume":"73","author":"H Ellis","year":"1993","unstructured":"Ellis H, Colborn GL, Skandalakis JE. Surgical embryology and anatomy of the breast and its related anatomic structures. Surg Clin North Am. 1993;73(4):611\u201332.","journal-title":"Surg Clin North Am"},{"issue":"9","key":"9548_CR21","first-page":"552","volume":"45","author":"LJ Skandalakis","year":"1979","unstructured":"Skandalakis LJ, Vohman MD, Skandalakis JE, Gray SW. The axillary lymph nodes in radical and modified radical mastectomy. Am Surg. 1979;45(9):552\u20135.","journal-title":"Am Surg"},{"issue":"2","key":"9548_CR22","first-page":"127","volume":"16","author":"U Veronesi","year":"1990","unstructured":"Veronesi U, Luini A, Galimberti V, Marchini S, Sacchini V, Rilke F. Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol. 1990;16(2):127\u201333.","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"9548_CR23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s10434-001-0837-3","volume":"8","author":"SD Nathanson","year":"2001","unstructured":"Nathanson SD, Wachna DL, Gilman D, Karvelis K, Havstad S, Ferrara J. Pathways of lymphatic drainage from the breast. Ann Surg Oncol. 2001;8(10):837\u201343.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"9548_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.breast.2010.03.022","volume":"19","author":"Y Fan","year":"2010","unstructured":"Fan Y, Xu B, Liao Y, Yao S, Sun Y. A retrospective study of metachronous and synchronous ipsilateral supraclavicular lymph node metastases in breast cancer patients. Breast 2010;19(5):365\u20139.","journal-title":"Breast"},{"issue":"34","key":"9548_CR25","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1200\/JCO.2014.55.2836","volume":"32","author":"A Berruti","year":"2014","unstructured":"Berruti A, Amoroso V, Gallo F, et al. Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies. J Clin Oncol. 2014;32(34):3883\u201391.","journal-title":"J Clin Oncol"},{"issue":"9938","key":"9548_CR26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 2014;384(9938):164\u201372.","journal-title":"Lancet"},{"issue":"22","key":"9548_CR27","doi-asserted-by":"publisher","first-page":"666","DOI":"10.21037\/atm.2019.10.22","volume":"7","author":"J Zhu","year":"2019","unstructured":"Zhu J, Jiao D, Guo X, et al. Predictive factors and prognostic value of pathologic complete response of ipsilateral supraclavicular lymph nodes in breast cancer after neoadjuvant chemotherapy. Ann Transl Med. 2019;7(22):666.","journal-title":"Ann Transl Med"}],"updated-by":[{"DOI":"10.1245\/s10434-021-09841-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000}}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09548-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-09548-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09548-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T20:12:31Z","timestamp":1628367151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-09548-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["9548"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-09548-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]},"assertion":[{"value":"23 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1245\/s10434-021-09841-y","URL":"https:\/\/doi.org\/10.1245\/s10434-021-09841-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Minhao Lv, Juntao Li, Huihui Guo, Chao Wang, Peiqi Tian, Youzhao Ma, Xiuchun Chen, and Suxia Luo declare no potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}